152 related articles for article (PubMed ID: 35023026)
21. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.
Zhou H; Wang YX; Lou HY; Xu XJ; Zhang MM
Korean J Radiol; 2014; 15(2):218-25. PubMed ID: 24643319
[TBL] [Abstract][Full Text] [Related]
22. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.
Guo T; Li X; Yang X; Kong X; Liu H; Bai T; Xu K; Ye J; Song Y
Sci Rep; 2019 Feb; 9(1):1231. PubMed ID: 30718698
[TBL] [Abstract][Full Text] [Related]
23. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
Jiang M; Wang L; Du X; Hao M; Gao P
J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
[TBL] [Abstract][Full Text] [Related]
24. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome.
Wang C; Wu X; Xie W; Ren X; Zhang W; Xu J
Sci Rep; 2019 Feb; 9(1):2179. PubMed ID: 30778132
[TBL] [Abstract][Full Text] [Related]
26. A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Wang W; Chen Y; Yin Y; Wang X; Ye X; Jiang K; Zhang Y; Zhang J; Zhang W; Zhuge Y; Chen L; Peng C; Xiong A; Yang L; Wang Z
Arch Toxicol; 2022 Jul; 96(7):2003-2019. PubMed ID: 35357534
[TBL] [Abstract][Full Text] [Related]
27. Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids.
Du X; Liu Z; Yu H; Wang Y; Zou Z; Wei H; Liang J; Yang D; Liu Y; Zhang J; Pan CQ
Medicine (Baltimore); 2023 Aug; 102(32):e34698. PubMed ID: 37565875
[TBL] [Abstract][Full Text] [Related]
28. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
Gao H; Li N; Wang JY; Zhang SC; Lin G
J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
[TBL] [Abstract][Full Text] [Related]
29. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Wu F; Yu J; Gan H; Zhang H; Tian D; Zheng D
Sci Rep; 2021 Nov; 11(1):21743. PubMed ID: 34741082
[TBL] [Abstract][Full Text] [Related]
30. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.
Zhang W; Liu L; Zhang M; Zhang F; Peng C; Zhang B; Chen J; Li L; He J; Xiao J; Feng Y; Wang X; Xiong A; Yang L; Zou X; Yu Y; Zhuge Y
J Clin Transl Hepatol; 2021 Jun; 9(3):345-352. PubMed ID: 34221920
[TBL] [Abstract][Full Text] [Related]
31. Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome.
Liu Z; Liang S; Wei X; Du X; Zhang J
BMC Gastroenterol; 2022 Dec; 22(1):525. PubMed ID: 36526956
[TBL] [Abstract][Full Text] [Related]
32. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
[TBL] [Abstract][Full Text] [Related]
33. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971
[TBL] [Abstract][Full Text] [Related]
34. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome.
Li X; Yang X; Xu D; Li Q; Kong X; Lu Z; Bai T; Xu K; Ye J; Song Y
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):955-957. PubMed ID: 28126425
[No Abstract] [Full Text] [Related]
35. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
Tan Y; Zhou X
Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
[TBL] [Abstract][Full Text] [Related]
36. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome.
Yang X; Lei P; Song Y; Fei Z; Ai Y; Shang H; Bai T; Ye J; Li X
Eur J Radiol; 2021 May; 138():109632. PubMed ID: 33711570
[TBL] [Abstract][Full Text] [Related]
37. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
[TBL] [Abstract][Full Text] [Related]
38. Proteomic study of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome in rats.
Li YH; Tai WC; Xue JY; Wong WY; Lu C; Ruan JQ; Li N; Wan TF; Chan WY; Hsiao WL; Lin G
Chem Res Toxicol; 2015 Sep; 28(9):1715-27. PubMed ID: 26280871
[TBL] [Abstract][Full Text] [Related]
39. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.
Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z
Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501
[TBL] [Abstract][Full Text] [Related]
40. Characterization of liver injury induced by a pyrrolizidine alkaloid in rats.
Chen X; Ma J; He Y; Xue J; Song Z; Xu Q; Lin G
Phytomedicine; 2021 Aug; 89():153595. PubMed ID: 34153877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]